Massive obstetric hemorrhage: Current approach to management.

Area of Science:

• Obstetrics and Gynecology
• Maternal Health
• Hemorrhage Management

Background:

• Massive obstetric hemorrhage is a significant global cause of maternal mortality and morbidity.
• Defined by significant blood loss (>2,500ml), it often necessitates critical care admission or hysterectomy.
• Pregnancy-related comorbidities can exacerbate bleeding and lead to consumption coagulopathy.

Purpose of the Study:

• To review strategies for optimizing outcomes in patients experiencing massive obstetric hemorrhage.
• To highlight the importance of preparation, resource management, and protocolized actions.
• To emphasize the role of rapid transfusion and specific factor replacement in managing postpartum hemorrhage.

Main Methods:

• Review of existing literature and clinical guidelines on massive obstetric hemorrhage.
• Discussion of diagnostic criteria and associated risks.
• Analysis of management strategies including transfusion protocols and coagulopathy correction.

Main Results:

• Protocolized management, including rapid transfusion, can improve patient outcomes and be cost-effective.
• Early identification and administration of fibrinogen are crucial for managing hypofibrinogenemia.
• Replacement of other coagulation factors may be necessary to correct coagulopathy.
• Hysterectomy is considered when conservative medical and surgical measures fail.

Conclusions:

• Effective management of massive obstetric hemorrhage relies on preparation, protocolization, and timely intervention.
• Early use of fibrinogen and other coagulation factors is vital for correcting coagulopathy.
• Aggressive management strategies, including hysterectomy if necessary, are essential to reduce maternal mortality and morbidity.